Good At

Specializing in pediatric diseases such as: Complications after infection of Changxinguan, rhinitis and sinusitis (Repeated coughing, nasal congestion, nasal discharge, nasal itching), infectious disease (Fever, cough, asthma, rash, vomiting, etc. caused by pneumonia, bronchitis, tonsillitis, gastroenteritis, hand, foot and mouth disease, etc.), upper respiratory infection (Fever, coughing, runny nose, nasal congestion), bronchitis, pneumonia (Fever, coughing, poor appetite), asthma (Chronic cough, shortness of breath, asthma), acute laryngitis (Hoarseness, barking and coughing), eczema (allergy, rash), chronic cough (allergy, poor resistance), encephalitis (convulsions, headache, vomiting), autumn diarrhea, acute gastroenteritis (vomiting, diarrhea, dehydration), acute abdomen in children (abdominal pain, hematochezia, vomiting), anemia (pale complexion), thrombocytopenia (skin bleeding spots), Kawasaki disease (fever, rash, enlarged lymph nodes, bulbar conjunctival congestion, bayberry tongue), etc.

Introduction

Ning Botao, male, doctoral supervisor, chief physician, MD, School of Medicine of Shanghai Jiao Tong University, postdoctoral fellow at the School of Medicine of the University of Hong Kong, and deputy director of the PICU of National Children's Medical Center and Shanghai Children's Medical Center. Selected into the first batch of Shanghai City Outstanding Young Medical Talent Program. Every year, about 10,000 outpatient clinics are completed and about 600 critically ill children are treated. The research team is committed to studying the mechanism of the bone marrow microenvironment and immune homeostasis in children with sepsis and clinical and basic research on other critical diseases in children, and exploring the transformed application of sepsis biomarkers in clinical diagnosis and treatment. In recent years, his first and corresponding authors (including co-authors) have published 40 SCI papers in international authoritative journals such as Signal Transduction and Targeted Therapy (2021), Medcom (2023), Frontiers in Immunology (2022). Engaged in clinical, scientific research and teaching work in pediatric medicine and critical pediatric diseases, specializing in the treatment of various pediatric medicine diseases, especially severe sepsis, multiple organ dysfunction syndrome and other critical diseases, and has rich clinical experience in advanced life support technologies such as intensive care and extracorporeal membrane oxygenation (ECMO) technology. Published more than 60 papers as first author and corresponding author.